NCT07831291Not yet recruiting
Childhood Obesity Risk Markers (MARIOBE)
Childhood Obesity Risk Markers
Source: ClinicalTrials.gov · Last updated 21 Sept 2026
Brief summary (registry, in English)
Metabolic diseases, including childhood obesity, represent a major public health challenge. Studies in mice have identified transcriptomic markers in adipose tissue capable of predicting a predisposition to obesity prior to any weight gain. The MARIOBE project aims to translate this approach to young children (≤ 4 years old) in order to identify individual vulnerability to obesity at an early stage.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- First submitted
- 8 Sept 2026
- Start date
- Sept 2026
- Primary completion date
- Sept 2036
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Diseases
- Obesity
- NCT number
- NCT07831291
What you commit to
- Study type: Interventional
- Planned participants: 400
- From Sept 2026 to the primary completion date, Sept 2036
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Child whose holders of parental authority are protected by law
Who the study is looking for
- Child scheduled for surgery allowing for the harvesting of adipose tissue.
Age in the registry: 1 day to 4 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Clermont-Ferrand Coordinator of this site? Confirm its status | Clermont-Ferrand | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.